Global Hospital-Acquired Pneumonia Prevention Market Size, Status and Forecast 2021-2027

院内肺炎予防の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Hospital-Acquired Pneumonia Prevention Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR2921
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:94
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、院内肺炎予防の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(オーラルケアキット、歯ブラシ、綿棒、保湿剤、うがい薬、吸引具)、用途別市場規模(病院、リハビリセンター、在宅介護施設)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・院内肺炎予防の市場動向
・企業の競争状況、市場シェア
・院内肺炎予防の種類別市場規模(オーラルケアキット、歯ブラシ、綿棒、保湿剤、うがい薬、吸引具)
・院内肺炎予防の用途別市場規模(病院、リハビリセンター、在宅介護施設)
・院内肺炎予防の北米市場規模2016-2027(アメリカ、カナダ)
・院内肺炎予防の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・院内肺炎予防のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・院内肺炎予防の中南米市場規模2016-2027(メキシコ、ブラジル)
・院内肺炎予防の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Halyard Health、Sage Products LLC、Intersurgical Ltd.、Medline Industries)
・結論

HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcare centers and increases the length of stay in ICU.

Market Analysis and Insights: Global Hospital-Acquired Pneumonia Prevention Market
The global Hospital-Acquired Pneumonia Prevention market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital-Acquired Pneumonia Prevention market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital-Acquired Pneumonia Prevention market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital-Acquired Pneumonia Prevention market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital-Acquired Pneumonia Prevention market.

Global Hospital-Acquired Pneumonia Prevention Scope and Market Size
Hospital-Acquired Pneumonia Prevention market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-Acquired Pneumonia Prevention market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Care Kit
Toothbrush
Swab
Moisturizer
Mouth Wash
Suction Tools

Segment by Application
Hospitals
Rehabilitation Centers
Home Care Settings

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Halyard Health
Sage Products LLC
Intersurgical Ltd.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Pneumonia Prevention Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Care Kit
1.2.3 Toothbrush
1.2.4 Swab
1.2.5 Moisturizer
1.2.6 Mouth Wash
1.2.7 Suction Tools
1.3 Market by Application
1.3.1 Global Hospital-Acquired Pneumonia Prevention Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Rehabilitation Centers
1.3.4 Home Care Settings
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hospital-Acquired Pneumonia Prevention Market Perspective (2016-2027)
2.2 Hospital-Acquired Pneumonia Prevention Growth Trends by Regions
2.2.1 Hospital-Acquired Pneumonia Prevention Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hospital-Acquired Pneumonia Prevention Historic Market Share by Regions (2016-2021)
2.2.3 Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Regions (2022-2027)
2.3 Hospital-Acquired Pneumonia Prevention Industry Dynamic
2.3.1 Hospital-Acquired Pneumonia Prevention Market Trends
2.3.2 Hospital-Acquired Pneumonia Prevention Market Drivers
2.3.3 Hospital-Acquired Pneumonia Prevention Market Challenges
2.3.4 Hospital-Acquired Pneumonia Prevention Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Pneumonia Prevention Players by Revenue
3.1.1 Global Top Hospital-Acquired Pneumonia Prevention Players by Revenue (2016-2021)
3.1.2 Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Players (2016-2021)
3.2 Global Hospital-Acquired Pneumonia Prevention Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hospital-Acquired Pneumonia Prevention Revenue
3.4 Global Hospital-Acquired Pneumonia Prevention Market Concentration Ratio
3.4.1 Global Hospital-Acquired Pneumonia Prevention Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Pneumonia Prevention Revenue in 2020
3.5 Hospital-Acquired Pneumonia Prevention Key Players Head office and Area Served
3.6 Key Players Hospital-Acquired Pneumonia Prevention Product Solution and Service
3.7 Date of Enter into Hospital-Acquired Pneumonia Prevention Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital-Acquired Pneumonia Prevention Breakdown Data by Type
4.1 Global Hospital-Acquired Pneumonia Prevention Historic Market Size by Type (2016-2021)
4.2 Global Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Type (2022-2027)

5 Hospital-Acquired Pneumonia Prevention Breakdown Data by Application
5.1 Global Hospital-Acquired Pneumonia Prevention Historic Market Size by Application (2016-2021)
5.2 Global Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hospital-Acquired Pneumonia Prevention Market Size (2016-2027)
6.2 North America Hospital-Acquired Pneumonia Prevention Market Size by Type
6.2.1 North America Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2021)
6.2.2 North America Hospital-Acquired Pneumonia Prevention Market Size by Type (2022-2027)
6.2.3 North America Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2027)
6.3 North America Hospital-Acquired Pneumonia Prevention Market Size by Application
6.3.1 North America Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2021)
6.3.2 North America Hospital-Acquired Pneumonia Prevention Market Size by Application (2022-2027)
6.3.3 North America Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2027)
6.4 North America Hospital-Acquired Pneumonia Prevention Market Size by Country
6.4.1 North America Hospital-Acquired Pneumonia Prevention Market Size by Country (2016-2021)
6.4.2 North America Hospital-Acquired Pneumonia Prevention Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hospital-Acquired Pneumonia Prevention Market Size (2016-2027)
7.2 Europe Hospital-Acquired Pneumonia Prevention Market Size by Type
7.2.1 Europe Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2021)
7.2.2 Europe Hospital-Acquired Pneumonia Prevention Market Size by Type (2022-2027)
7.2.3 Europe Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2027)
7.3 Europe Hospital-Acquired Pneumonia Prevention Market Size by Application
7.3.1 Europe Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2021)
7.3.2 Europe Hospital-Acquired Pneumonia Prevention Market Size by Application (2022-2027)
7.3.3 Europe Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2027)
7.4 Europe Hospital-Acquired Pneumonia Prevention Market Size by Country
7.4.1 Europe Hospital-Acquired Pneumonia Prevention Market Size by Country (2016-2021)
7.4.2 Europe Hospital-Acquired Pneumonia Prevention Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size (2016-2027)
8.2 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Type
8.2.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2027)
8.3 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Application
8.3.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2027)
8.4 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Region
8.4.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hospital-Acquired Pneumonia Prevention Market Size (2016-2027)
9.2 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Type
9.2.1 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2021)
9.2.2 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Type (2022-2027)
9.2.3 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2027)
9.3 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Application
9.3.1 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2021)
9.3.2 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Application (2022-2027)
9.3.3 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2027)
9.4 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Country
9.4.1 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Country (2016-2021)
9.4.2 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size (2016-2027)
10.2 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Type
10.2.1 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2027)
10.3 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Application
10.3.1 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2027)
10.4 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Country
10.4.1 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Halyard Health
11.1.1 Halyard Health Company Details
11.1.2 Halyard Health Business Overview
11.1.3 Halyard Health Hospital-Acquired Pneumonia Prevention Introduction
11.1.4 Halyard Health Revenue in Hospital-Acquired Pneumonia Prevention Business (2016-2021)
11.1.5 Halyard Health Recent Development
11.2 Sage Products LLC
11.2.1 Sage Products LLC Company Details
11.2.2 Sage Products LLC Business Overview
11.2.3 Sage Products LLC Hospital-Acquired Pneumonia Prevention Introduction
11.2.4 Sage Products LLC Revenue in Hospital-Acquired Pneumonia Prevention Business (2016-2021)
11.2.5 Sage Products LLC Recent Development
11.3 Intersurgical Ltd.
11.3.1 Intersurgical Ltd. Company Details
11.3.2 Intersurgical Ltd. Business Overview
11.3.3 Intersurgical Ltd. Hospital-Acquired Pneumonia Prevention Introduction
11.3.4 Intersurgical Ltd. Revenue in Hospital-Acquired Pneumonia Prevention Business (2016-2021)
11.3.5 Intersurgical Ltd. Recent Development
11.4 Medline Industries
11.4.1 Medline Industries Company Details
11.4.2 Medline Industries Business Overview
11.4.3 Medline Industries Hospital-Acquired Pneumonia Prevention Introduction
11.4.4 Medline Industries Revenue in Hospital-Acquired Pneumonia Prevention Business (2016-2021)
11.4.5 Medline Industries Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hospital-Acquired Pneumonia Prevention Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Care Kit
Table 3. Key Players of Toothbrush
Table 4. Key Players of Swab
Table 5. Key Players of Moisturizer
Table 6. Key Players of Mouth Wash
Table 7. Key Players of Suction Tools
Table 8. Global Hospital-Acquired Pneumonia Prevention Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hospital-Acquired Pneumonia Prevention Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Hospital-Acquired Pneumonia Prevention Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Hospital-Acquired Pneumonia Prevention Market Share by Regions (2016-2021)
Table 12. Global Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Hospital-Acquired Pneumonia Prevention Market Share by Regions (2022-2027)
Table 14. Hospital-Acquired Pneumonia Prevention Market Trends
Table 15. Hospital-Acquired Pneumonia Prevention Market Drivers
Table 16. Hospital-Acquired Pneumonia Prevention Market Challenges
Table 17. Hospital-Acquired Pneumonia Prevention Market Restraints
Table 18. Global Hospital-Acquired Pneumonia Prevention Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Hospital-Acquired Pneumonia Prevention Market Share by Players (2016-2021)
Table 20. Global Top Hospital-Acquired Pneumonia Prevention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Acquired Pneumonia Prevention as of 2020)
Table 21. Ranking of Global Top Hospital-Acquired Pneumonia Prevention Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Hospital-Acquired Pneumonia Prevention Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hospital-Acquired Pneumonia Prevention Product Solution and Service
Table 25. Date of Enter into Hospital-Acquired Pneumonia Prevention Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Type (2016-2021)
Table 29. Global Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Hospital-Acquired Pneumonia Prevention Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Application (2016-2021)
Table 33. Global Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Hospital-Acquired Pneumonia Prevention Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Hospital-Acquired Pneumonia Prevention Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Hospital-Acquired Pneumonia Prevention Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Hospital-Acquired Pneumonia Prevention Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Hospital-Acquired Pneumonia Prevention Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Hospital-Acquired Pneumonia Prevention Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Hospital-Acquired Pneumonia Prevention Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Hospital-Acquired Pneumonia Prevention Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Hospital-Acquired Pneumonia Prevention Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Hospital-Acquired Pneumonia Prevention Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Hospital-Acquired Pneumonia Prevention Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Hospital-Acquired Pneumonia Prevention Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Country (2022-2027) & (US$ Million)
Table 65. Halyard Health Company Details
Table 66. Halyard Health Business Overview
Table 67. Halyard Health Hospital-Acquired Pneumonia Prevention Product
Table 68. Halyard Health Revenue in Hospital-Acquired Pneumonia Prevention Business (2016-2021) & (US$ Million)
Table 69. Halyard Health Recent Development
Table 70. Sage Products LLC Company Details
Table 71. Sage Products LLC Business Overview
Table 72. Sage Products LLC Hospital-Acquired Pneumonia Prevention Product
Table 73. Sage Products LLC Revenue in Hospital-Acquired Pneumonia Prevention Business (2016-2021) & (US$ Million)
Table 74. Sage Products LLC Recent Development
Table 75. Intersurgical Ltd. Company Details
Table 76. Intersurgical Ltd. Business Overview
Table 77. Intersurgical Ltd. Hospital-Acquired Pneumonia Prevention Product
Table 78. Intersurgical Ltd. Revenue in Hospital-Acquired Pneumonia Prevention Business (2016-2021) & (US$ Million)
Table 79. Intersurgical Ltd. Recent Development
Table 80. Medline Industries Company Details
Table 81. Medline Industries Business Overview
Table 82. Medline Industries Hospital-Acquired Pneumonia Prevention Product
Table 83. Medline Industries Revenue in Hospital-Acquired Pneumonia Prevention Business (2016-2021) & (US$ Million)
Table 84. Medline Industries Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital-Acquired Pneumonia Prevention Market Share by Type: 2020 VS 2027
Figure 2. Oral Care Kit Features
Figure 3. Toothbrush Features
Figure 4. Swab Features
Figure 5. Moisturizer Features
Figure 6. Mouth Wash Features
Figure 7. Suction Tools Features
Figure 8. Global Hospital-Acquired Pneumonia Prevention Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Rehabilitation Centers Case Studies
Figure 11. Home Care Settings Case Studies
Figure 12. Hospital-Acquired Pneumonia Prevention Report Years Considered
Figure 13. Global Hospital-Acquired Pneumonia Prevention Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Hospital-Acquired Pneumonia Prevention Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Hospital-Acquired Pneumonia Prevention Market Share by Regions: 2020 VS 2027
Figure 16. Global Hospital-Acquired Pneumonia Prevention Market Share by Regions (2022-2027)
Figure 17. Global Hospital-Acquired Pneumonia Prevention Market Share by Players in 2020
Figure 18. Global Top Hospital-Acquired Pneumonia Prevention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Acquired Pneumonia Prevention as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Hospital-Acquired Pneumonia Prevention Revenue in 2020
Figure 20. Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Type (2016-2021)
Figure 21. Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Type (2022-2027)
Figure 22. North America Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Hospital-Acquired Pneumonia Prevention Market Share by Type (2016-2027)
Figure 24. North America Hospital-Acquired Pneumonia Prevention Market Share by Application (2016-2027)
Figure 25. North America Hospital-Acquired Pneumonia Prevention Market Share by Country (2016-2027)
Figure 26. United States Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Hospital-Acquired Pneumonia Prevention Market Share by Type (2016-2027)
Figure 30. Europe Hospital-Acquired Pneumonia Prevention Market Share by Application (2016-2027)
Figure 31. Europe Hospital-Acquired Pneumonia Prevention Market Share by Country (2016-2027)
Figure 32. Germany Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Share by Region (2016-2027)
Figure 42. China Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Hospital-Acquired Pneumonia Prevention Market Share by Type (2016-2027)
Figure 50. Latin America Hospital-Acquired Pneumonia Prevention Market Share by Application (2016-2027)
Figure 51. Latin America Hospital-Acquired Pneumonia Prevention Market Share by Country (2016-2027)
Figure 52. Mexico Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Share by Country (2016-2027)
Figure 58. Turkey Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Hospital-Acquired Pneumonia Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Halyard Health Revenue Growth Rate in Hospital-Acquired Pneumonia Prevention Business (2016-2021)
Figure 62. Sage Products LLC Revenue Growth Rate in Hospital-Acquired Pneumonia Prevention Business (2016-2021)
Figure 63. Intersurgical Ltd. Revenue Growth Rate in Hospital-Acquired Pneumonia Prevention Business (2016-2021)
Figure 64. Medline Industries Revenue Growth Rate in Hospital-Acquired Pneumonia Prevention Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[院内肺炎予防の世界市場規模・現状・予測2021年-2027年] (Global Hospital-Acquired Pneumonia Prevention Market Size, Status and Forecast 2021-2027 / QY21APR2921)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆